66737-89-1

Basic information

• Product Name: Benzoic acid, 3-(1,1-dimethylethyl)-4-methoxy-
• CAS NO: 66737-89-1
• Molecular Formula: C12H16O3
• Molecular Weight: 208.257
• Mol File: 66737-89-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-(1,1-dimethylethyl)-4-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-(1,1-dimethylethyl)-4-methoxy-(66737-89-1)
• EPA Substance Registry System: Benzoic acid, 3-(1,1-dimethylethyl)-4-methoxy-(66737-89-1)

Safety Data

• Hazardous Substances Data: 66737-89-1(Hazardous Substances Data)

Upstream product

• 124-38-9 carbon dioxide 
• 14804-34-3 3-tert-butyl-4-methoxybromobenzene 
• 125182-27-6 methyl 3-tert-butyl-4-methoxybenzoate 

Downstream Products

• 66737-88-0 4-hydroxy-3-tert-butyl benzoic acid 
• 171365-85-8 ethyl 4-<(E)-2-(3-tert-butyl-4-methoxyphenyl)propenyl>benzoate 
• 142651-19-2 1-(3-(tert-butyl)-4-methoxyphenyl)ethan-1-one 

Relevant articles and documents

BICYCLIC COMPOUNDS USEFUL AS CATHEPSIN S INBHIBITORS

Compounds of formula (I), wherein R1, R2, R3, Ra and E are are defined within, and pharmaceutically acceptable salts, solvates, hydrates and N-oxides thereof having utility in the treatment of disorders mediated by cathepsin S.

Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity

The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.

Benzo (b) thiophene carboxylate derivatives and pharmaceutical compositions

Aromatic heterocyclic derivatives have the formula STR1 wherein R1 represents STR2 wherein R3 represents hydrogen, --OR4 wherein R4 represents hydrogen, alkyl having 1-20 carbon atoms or mono- or polyhydroxyalkyl or R3 represents STR3 wherein r' and r" represent hydrogen, lower alkyl or together form a heterocycle, R2 represents hydrogen or --CH3 and Ar represents STR4 wherein Z is O or S, STR5 wherein R5 is lower alkyl or STR6 wherein R6 is hydrogen or alkyl having 1-10 carbon atoms and R7 represents alkyl having 4-12 carbon atoms or cycloalkyl, Y is CH or a nitrogen atom and X represents oxygen, sulfur or --N--R8 when R8 represents hydrogen, lower alkyl or lower alkoxycarbonyl, with the proviso that (i) when Y is CH and X is oxygen or sulfur Ar is other than C and (ii) when Y is nitrogen and X is oxygen, Ar is other than (C) or (D) in which R6 is alkyl having 1-4 carbon atoms and R7 is branched alkyl having 4-12 atoms useful in veterinary or human therapy and in cosmetic formulations.